Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - methenamine hippurate, quantity: 1000 mg - tablet, uncoated - excipient ingredients: colloidal anhydrous silica; povidone; magnesium stearate - prophylaxis or suppression of bacteriuria associated with chronic or recurrent infection of the urinary tract.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - methenamine hippurate, quantity: 1000 mg - tablet, uncoated - excipient ingredients: povidone; colloidal anhydrous silica; magnesium stearate - prophylaxis or suppression of bacteriuria associated with chronic or recurrent infection of the urinary tract.

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

sipcam pacific australia pty. limited - indole acetic acid = iaa; naphthalene acetic acid; vitamin b1 - liquid concentrate - indole acetic acid = iaa plant growth regulator active 0.075 g/l; naphthalene acetic acid plant growth regulator active 0.075 g/l; vitamin b1 vitamin-b1 other 2.25 g/l - plant regulator - cutting | golf green turf | lawn | oval | piping | playing field | sugar cane setts | turf | sugarcane setts - acceleration of root development growth

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

duluxgroup (australia) pty ltd - indole acetic acid = iaa; naphthylacetic acid = naa - wettable powder - indole acetic acid = iaa plant growth regulator active 0.05 g/kg; naphthylacetic acid = naa plant growth regulator active 0.02 g/kg - growth promoter - propogation of plant material - striking plant cuttings

Australia - English - Department of Health (Therapeutic Goods Administration)

lundbeck australia pty ltd - sertindole -

New Zealand - English - Medsafe (Medicines Safety Authority)

astrazeneca limited - zolmitriptan 5mg - nasal spray solution - 5 mg - active: zolmitriptan 5mg excipient: citric acid dibasic sodium phosphate dihydrate purified water

New Zealand - English - Medsafe (Medicines Safety Authority)

astrazeneca limited - zolmitriptan 50 mg/ml - nasal spray solution - 5 mg/dose - active: zolmitriptan 50 mg/ml excipient: citric acid dibasic sodium phosphate dihydrate purified water

Australia - English - Department of Health (Therapeutic Goods Administration)

janssen-cilag pty ltd - bendamustine hydrochloride, quantity: 25 mg - injection, powder for - excipient ingredients: mannitol - first-line treatment of chronic lymphocytic leukaemia (binet stage b or c). efficacy relative to first-line therapies other than chlorambucil has not been established. previously untreated indolent cd20-positive, stage iii-iv non-hodgkin?s lymphoma, in combination with rituximab. previously untreated cd20-positive, stage iii-iv mantle cell lymphoma in combination with rituximab, in patients ineligible for autologous stem cell transplantation. relapsed/refractory indolent non-hodgkin?s lymphoma.

Australia - English - Department of Health (Therapeutic Goods Administration)

janssen-cilag pty ltd - bendamustine hydrochloride, quantity: 100 mg - injection, powder for - excipient ingredients: mannitol - first-line treatment of chronic lymphocytic leukaemia (binet stage b or c). efficacy relative to first-line therapies other than chlorambucil has not been established. previously untreated indolent cd20-positive, stage iii-iv non-hodgkin?s lymphoma, in combination with rituximab. previously untreated cd20-positive, stage iii-iv mantle cell lymphoma in combination with rituximab, in patients ineligible for autologous stem cell transplantation. relapsed/refractory indolent non-hodgkin?s lymphoma.

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - gentamicin sulfate, quantity: 16.13 mg/ml - injection, solution - excipient ingredients: disodium edetate; water for injections; sulfuric acid; sodium hydroxide - indications as at 31 october 2003: gentamicin injection is indicated in the treatment of serious infections caused by susceptible strains of the following microorganisms: pseudomonas aeruginosa, proteus species (indole positive and indole negative), escherichia coli, klebsiella - enterobacter - serratia species, staphylococcus species (coagulase positive and coagulase negative). gentamicin injection should be considered for the treatment of the following conditions when caused by susceptible organisms: septicaemia, respiratory tract infections, infected wounds, bone and soft tissue infections including peritonitis, septic abortion and burns complicated by sepsis, urinary tract infections (recurrent, complicated). gentamicin injection is not routinely indicated in the initial treatment of uncomplicated urinary tract infections unless the organism is resistant to other less toxic antibacterials. gentamicin injection may be considered as initial therapy in suspected or confirmed gram negative infections and ther